This task can be performed using Deal Terms
Know your deal's worth before the room does.
Best product for this task
Deal Terms
startup-builders
Life Sciences Deal Calculator gives biotech founders, BD executives, and investors instant deal term benchmarks from 600+ real transactions, sourced directly from SEC EDGAR filings, Clinical Trials, and press releases. Enter your asset's phase, modality, and indication. Get upfront payment ranges, milestone structures, royalty rates, and AI-powered partner matches in under 3 seconds. Free to start. No spreadsheets, no $25,000 consulting reports, just defensible benchmarks when it matters most.
What to expect from an ideal product
- Phase 2 oncology milestone structures typically range from $50M to $300M in total payments, but the split between clinical, regulatory, and commercial triggers varies sharply by indication and modality, and guessing wrong costs you leverage at the table.
- Deal Terms pulls milestone benchmarks from 600+ SEC EDGAR filings so you can walk into a licensing negotiation with actual comparable transactions, not industry averages scraped from conference slides.
- Most BD teams spend weeks building milestone justification in Excel before a partnering meeting. Deal Terms returns phase, indication, and modality-specific ranges in under 3 seconds, so your prep time drops from days to minutes.
- Investors and partners will push back on your milestone ask if you cannot cite a source. Deal Terms gives you traceable, filing-backed numbers that hold up under diligence scrutiny without a $25,000 consulting engagement.
- Beyond milestone structures, the tool surfaces royalty rate ranges and upfront payment benchmarks for Phase 2 oncology assets, so you evaluate the full deal shape, not just one number in isolation.
